Proteins Commonly Linked to Autism Spectrum Disorder and Alzheimer's Disease

被引:15
作者
Alexiou, Athanasios [1 ]
Soursou, Georgia [1 ,2 ]
Yarla, Nagendra Sastry [3 ]
Ashraf, Ghulam Md [4 ]
机构
[1] Novel Global Community Educ Fdn, 7 Peterlee Pl, Hebersham, NSW 2770, Australia
[2] Univ Crete, Med Sch, Bioinformat Grad Program, Iraklion, Greece
[3] GITAM Univ, Sch Life Sci, Dept Biochem & Bioinformat, Inst Sci, Visakhapatnam, Andhra Prades, India
[4] King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia
关键词
Autism spectrum disorder; Alzheimer's disease; proteins; developmental origins of health and diseases; neurological symptoms; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; DOWN-SYNDROME; BETA; TRANSMISSION; PLASTICITY; DEPOSITION; NUTRITION; PATHOLOGY; DENSITY;
D O I
10.2174/1389203718666170911145321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several years after the first publication of Barker's Hypothesis the identification of common patterns and pathways between genetic and epigenetic risk factors in neurodegenerative disorders is still an open problem. For the cases of Alzheimer's disease and Autism and by taking into consideration the increasing number of diagnosed cases globally, scientists focused on commonly expressed and related proteins like Amyloid beta and the mechanisms of their underlying dysfunctionalities. In this review paper, an attempt to specify significant correlations between proteins linked to Autism Spectrum Disorders and Alzheimer's Disease is presented. Both diseases are highlighted with an emphasis on the macromolecules that play a fundamental role in their development. These proteins are described and analyzed concerning the underlying pathology of these diseases.
引用
收藏
页码:876 / 880
页数:5
相关论文
共 48 条
[11]   Where, when, and in what form does sporadic Alzheimer's disease begin? [J].
Braak, Heiko ;
Del Tredici, Kelly .
CURRENT OPINION IN NEUROLOGY, 2012, 25 (06) :708-714
[12]  
Crisan C., 2016, BIOLOGY, P4150
[13]   MHC Class I Limits Hippocampal Synapse Density by Inhibiting Neuronal Insulin Receptor Signaling [J].
Dixon-Salazar, Tracy J. ;
Fourgeaud, Lawrence ;
Tyler, Carolyn M. ;
Poole, Julianna R. ;
Park, Joseph J. ;
Boulanger, Lisa M. .
JOURNAL OF NEUROSCIENCE, 2014, 34 (35) :11844-11856
[14]  
El-baz F., 2010, The Egyptian Journal of Medical Human Genetics, V11, P135
[15]   ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].
GAMES, D ;
ADAMS, D ;
ALESSANDRINI, R ;
BARBOUR, R ;
BERTHELETTE, P ;
BLACKWELL, C ;
CARR, T ;
CLEMENS, J ;
DONALDSON, T ;
GILLESPIE, F ;
GUIDO, T ;
HAGOPIAN, S ;
JOHNSONWOOD, K ;
KHAN, K ;
LEE, M ;
LEIBOWITZ, P ;
LIEBERBURG, I ;
LITTLE, S ;
MASLIAH, E ;
MCCONLOGUE, L ;
MONTOYAZAVALA, M ;
MUCKE, L ;
PAGANINI, L ;
PENNIMAN, E ;
POWER, M ;
SCHENK, D ;
SEUBERT, P ;
SNYDER, B ;
SORIANO, F ;
TAN, H ;
VITALE, J ;
WADSWORTH, S ;
WOLOZIN, B ;
ZHAO, J .
NATURE, 1995, 373 (6514) :523-527
[16]   Tau Proteins and Neurofibrillary Degeneration [J].
Goedert, M. ;
Spillantini, M. G. ;
Crowther, R. A. .
BRAIN PATHOLOGY, 1991, 1 (04) :279-286
[17]   AMYLOID DEPOSITION AS THE CENTRAL EVENT IN THE ETIOLOGY OF ALZHEIMERS-DISEASE [J].
HARDY, J ;
ALLSOP, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) :383-388
[18]   Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases [J].
Hashimoto, M ;
Rockenstein, E ;
Crews, L ;
Masliah, E .
NEUROMOLECULAR MEDICINE, 2003, 4 (1-2) :21-35
[19]   Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial [J].
Holmes, Clive ;
Boche, Delphine ;
Wilkinson, David ;
Yadegarfar, Ghasem ;
Hopkins, Vivienne ;
Bayer, Anthony ;
Jones, Roy W. ;
Bullock, Roger ;
Love, Seth ;
Neal, James W. ;
Zotova, Elina ;
Nicoll, James A. R. .
LANCET, 2008, 372 (9634) :216-223
[20]   Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein [J].
Hooper, NM .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 :335-338